Investigational CAR T-Cell Therapy Zola-Cel Under Scrutiny Following Fatal Event in MS Trial on October 24, 2026 Posted by
The Silent Surge: Why Strokes Are Targeting Younger Adults at Alarming Rates on October 24, 2026 Posted by
Bridging the Gap: ERS Joins Global Coalition to Champion Scientific Integrity and Public Health on October 24, 2026 Posted by
The Evolution of Hope: Understanding the Significance of National Recovery Month on October 24, 2026 Posted by
Bridging the Gap: New Bipartisan Legislative Push Targets Substance Use Recovery and Treatment Infrastructure on October 24, 2026 Posted by
The Future of Healing: CRI’s 2026 Gala Spotlights the "Next is Now" Era of Immunotherapy on October 24, 2026 Posted by
The Invisible Obstacle: How Fluid Viscosity Fuels Glioblastoma Aggression on October 24, 2026 Posted by
Investigational CAR T-Cell Therapy Zola-Cel Under Scrutiny Following Fatal Event in MS Trial on October 24, 2026 Posted by
The Silent Surge: Why Strokes Are Targeting Younger Adults at Alarming Rates on October 24, 2026 Posted by
Bridging the Gap: ERS Joins Global Coalition to Champion Scientific Integrity and Public Health on October 24, 2026 Posted by
The Evolution of Hope: Understanding the Significance of National Recovery Month on October 24, 2026 Posted by
Posted in Medical Innovations A New Era for RNAi: ADARx Pharmaceuticals Breaks Decade-Long IPO Drought on September 27, 2026
Posted in Medical Innovations ADARx Pharmaceuticals Breaks Decade-Long Stagnation with Landmark RNAi IPO on September 25, 2026
Posted in Medical Innovations Moonwalk Biosciences Secures $70M to Pivot Toward RNAi-Based Obesity Therapies on September 8, 2026
Posted in Medical Innovations Alnylam Fights Back: Biotech Defends RNAi Therapeutics Following AstraZeneca Trial Setback on August 30, 2026
Posted in Medical Innovations From Transformer Architecture to RNAi: The Billion-Dollar Convergence of AI and Biotechnology on June 4, 2026 rifanmuazin
